挪威≤7cm肾癌肿瘤手术治疗的国家实践模式:遵循指南变化可能改善总生存
基于挪威癌症登记处2008-2013年2420例≤7cm无转移肾癌手术患者的人群数据,评估手术实践是否随指南变化。研究期间手术量增加28%,部分肾切除术(PN)和微创(MI)入路均增加,PN与MI在高容量医院更常见。PN、年龄、Fuhrman分级和分期是生存的独立预测因素,T1a期PN后5年相对生存高于根治性肾切除术(RN)。
要点
- 2008-2013年挪威≤7cm肾癌手术量增加28%,PN和MI入路均增加,与2010年指南更新同步。
- 肿瘤≤4cm的PN从43%升至66%,4.1-7cm从10%升至18%;MI RN从53%升至72%,MI PN从25%升至64%。
- PN、年龄、Fuhrman分级和分期为生存独立预测因素;T1a期PN后5年相对生存高于RN。
核心结论
- 研究期间≤7cm肾癌肿瘤的PN率增加,RN和PN的MI入路均增加,治疗转变与2010年新指南推荐同步。
- PN相较于RN可能带来更好的生存,提示遵循循证指南的重要性。
研究设计与样本
- 基于挪威癌症登记处的人群数据,纳入2008-2013年诊断的≤7cm无转移且接受手术治疗的肾癌患者2420例。
- 使用joinpoint回归、多因素logistic回归、Kaplan-Meier生存估计、Cox回归、相对生存(RS)和竞争风险分析。
主要发现
- 研究期间接受手术治疗的患者数量增加28%。
- joinpoint回归显示PN年显著增加,RN小幅减少;肿瘤≤4cm的PN从43%升至66%,4.1-7cm从10%升至18%。
- MI RN从53%升至72%,MI PN从25%升至64%,2013年55%的手术采用机器人辅助。
- 治疗方式的地理分布差异显著,PN和MI入路在高容量医院更常见。
- Cox回归显示PN、年龄、Fuhrman分级和分期是生存的独立预测因素;癌症特异性生存无显著差异(p=0.8);T1a期PN后5年RS高于RN。
关键数值与推荐
- 平均随访5.2年。
- 肿瘤≤4cm的PN从43%升至66%,4.1-7cm从10%升至18%。
- MI RN从53%升至72%,MI PN从25%升至64%,2013年55%的手术采用机器人辅助。
- 癌症特异性生存无显著差异(p=0.8)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines on surgical treatment for kidney cancer (KC) have changed over the last 10 yr. We present population-based data for patients with KC tumors ≤7cm from 2008 to 2013 to investigate whether surgical practice in Norway has changed according to guidelines. OBJECTIVE: To assess the predictors of treatment and survival after KC surgery. DESIGN, SETTING, AND PARTICIPANTS: We identified all surgically treated KC patients with tumors ≤7cm without metastasis diagnosed during 2008-2013 (2420 patients) from the Cancer Registry of Norway. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Relationships with outcomes were analyzed using joinpoint regression, multivariate logistic regression, Kaplan-Meier survival estimates, Cox regression, relative survival (RS), and competing-risk analyses. RESULTS AND LIMITATIONS: The mean follow-up was 5.2 yr. There was a 28% increase in the number of patients undergoing surgical treatment over the study period. Joinpoint regression revealed a significant annual increase in partial nephrectomy (PN) and a small reduction in radical nephrectomy (RN). PN increased from 43% to 66% for tumors ≤4cm and from 10% to 18% for tumors of 4.1-7cm. Minimally invasive (MI) RN increased from 53% to 72% and MI PN from 25% to 64%, of which 55% of procedures were performed with robotic assistance in 2013. The geographical distribution of treatment approaches differed significantly. Both PN and MI approaches were more frequent in high-volume hospitals. Cox regression analysis revealed that PN, age, and Fuhrman grade and stage were independent predictors of survival. There were no significant differences in cancer-specific survival (p=0.8). The 5-yr RS for T1a disease was higher after PN than after RN. CONCLUSIONS: The rate of PN for tumors ≤7cm increased in the 6-yr study period. MI approaches increased for both RN and PN. This treatment shift coincides with the new guideline recommendations in 2010. The possible better survival for patients undergoing PN compared to RN indicates the importance of following evidence-based guidelines. PATIENT SUMMARY: The use of partial nephrectomy and minimally invasive surgery for kidney cancer tumors increased in Norway from 2008 to 2013 according to population-based data, coinciding with guideline changes. The study illustrate that adherence to guidelines may improve patient outcomes.
引用
- Hjelle KM, Johannesen TB, Bostad L, et al. National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival. Eur Urol Oncol. 2018. PMID: 31102628. doi:10.1016/j.euo.2018.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。